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Dexamethasone, a synthetic glucocorticoid (GC), is clinically administered to woman at risk for premature labor to 
induce fetal lung maturation. However, exposure to repeated or excess GCs leads to intrauterine growth restriction (IUGR) 
and subsequently increases risk of psychiatric and cardio-metabolic diseases in later life through fetal programming 
mechanisms. GCs are key mediators of stress responses, therefore, maternal nutrient restriction or psychological stress 
during pregnancy also causes negative impacts on birth and neurodevelopment outcome of fetuses, and other congenital 
defects, such as craniofacial and skeletal abnormalities. In this study, to examine the effect of prenatal stress on fetal 
skeletal development, dexamethasone (1 mg/kg [DEX1] or 10 mg/kg [DEX10] maternal body weight per day) was 
administered intraperitoneally at gestational day 7.5~9.5 and the skeletons were prepared from embryos at day 18.5. 
Seven out of eighteen (39%) embryos treated with DEX10 showed axial skeletal abnormalities in either the T13 or L1 
vertebrae. In addition, examination of the sternum revealed that xiphoid process, the protrusive triangular part of the 
lower end of the sternum, was bent more outward or inward in DEX group embryos. In conclusion, our findings suggest 
a possible link to the understanding of the effect of uterine environment to the fetal skeletal features. 
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INTRODUCTION 
 
Glucocorticoids (GCs) are involved in normal develop- 
mental processes of diverse organs such as kidneys, lung, 
heart, pancreas, and gut. As GC has multiple metabolic and 
immunological effects, it is usually applied to treat patients 
with inflammatory, allergic, and immune disorders in 
children and adults. Although it has many positive effects 
with drug use, patients taking chronic GC therapy often 
suffer from potential side effects, in particular on the skeleton, 
including growth retardation during childhood and decreased 
bone quality in adults (Canalis 2005; Henneicke et al., 
2014). During pregnancy, GC is clinically administered to 
pregnant woman at risk for premature labor to induce fetal 
lung maturation (Ward 1994; Sloboda et al., 2005). Despite 
the clear benefits of antenatal GC therapy, exposure to 
repeated or excess GCs have been known to cause a intrau- 
terine growth restriction and subsequently increased risk of 
psychiatric and cardio-metabolic diseases in later life 
(Newnham and Moss 2001). Besides, different types of 
prenatal stress during pregnancy have been also revealed to 
cause other congenital defects, such as craniofacial and 
skeletal anomalies as well as a reduction of birth weight, in 
a variety of animal models (Śliwa et al., 2006; Lee et al., 
2008; Choe et al., 2011). 
A few studies have demonstrated the effect of prenatal 
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stress and excess glucocorticoid on fetal skeletal develop- 
ment, and on skeletal growth and bone mineralization after 
birth as a long-term effect (Swolin-Eide et al., 2002; Śliwa 
et al., 2006; Lee et al., 2008; Choe et al., 2011). However, 
there is still no coherent connection between a specific type 
of stressor and the concomitant skeletal changes. Since the 
prenatal stress affects on different tissues in a variety of 
different ways, particularly during vulnerable periods of 
developmental processes, more evidence is needed to deter- 
mine the relationship between prenatal experiences and the 
skeletal growth and the bone health in later life. 
We have recently demonstrated that administration of 
dexamethasone (DEX), a synthetic GC, during the gesta- 
tional day 7.5~9.5 of pregnant mice causes placental defect 
and embryonic growth restriction in a sex-dependent manner 
(Lee et al., 2012; Yun et al., 2014). Here, we examined the 
effect of prenatal DEX treatment on fetal skeletal develop- 
ment on day 18.5. Developmental defects of the axial 
skeleton found in this model will provide an insight into 
the long-lasting effect of prenatal GC on the growth and 
the maturity of the skeleton. 
 
MATERIALS AND METHODS 
Experimental animals and injection of DEX 
All animals were handled according to the guideline for 
the Care and Use of Laboratory Animals of Yonsei 
University College of Medicine. The protocol for obtaining 
embryos was approved by the Committee on Animal 
Research at Yonsei University College of Medicine. Pregnant 
ICR mice were ordered from Orient Biology (Sungnam, 
Korea). DEX administration was performed as previously 
described (Lee et al., 2012). Briefly, either saline (control 
group) or dexamethasone 21-phosphate disodium salt (1 mg/ 
kg or 10 mg/kg, Sigma-Aldrich, St. Louis, MO, USA) was 
injected on days 7.5, 8.5 and 9.5 of gestation intraperitoneally. 
Embryo extraction and skeleton preparation 
The mice were sacrificed at 10 a.m. on gestational day 
18.5 using a carbon dioxide chamber. Embryos were 
extracted from the womb and the body weight and CRL 
(Crown-rump length) measured. Each sample's skin and 
internal organs in the chest cavity and lower trunk were 
removed after being incubated at 70℃ for 1 hour. They 
were fixed in 95% ethanol for 2~4 days and transferred to 
glass bottles containing acetone and kept overnight. Each 
sample was washed and stained with 0.03% Alcian Blue 
solution (Sigma) overnight. After being put in 95% ethanol 
for 3 hours, the embryos were stored in 2% potassium 
hydroxide in distilled water (DW) for 24 hours and stained 
with 0.005% Alizarin Red solution (Sigma) for 16 hours. 
The samples were then cleared in 1% potassium hydroxide 
in 20% glycerol for 2 days and transferred to increasingly 
concentrated glycerol solutions (50% to 80% glycerol in 
95% ethanol solution for 1 day each). 
Microscope observation and identification 
The samples were observed using a light microscope 
(Olympus SZX10) under varying degrees of brightness and 
hue. Each spinal column was identified using dorsal and 
ventral views of the trunk and several anatomical landmarks 
(T6 and T7 ribs conjoin near the end of the sternum, 
vertebral columns after caudal 4 lack dorsal processes, etc.). 
Embryos exposed to DEX were compared to specimens of 
the control group for abnormalities in the skeletal structure. 
 
RESULTS 
Effect of prenatal DEX treatment on fetal vertebral 
column 
A total of 36 embryos (18 embryos from 3 mothers with 
saline, and the same number with 1 mg/kg of DEX (DEX1) 
and 10 mg/kg of DEX (DEX10), respectively) were pro- 
cessed for skeletal preparation at gestational day 18.5. As 
far as the skeletal system is concerned, all the structures in 
the vertebral column including cervical, thoracic, lumbar, 
sacral and caudal were examined and overall no significant 
difference was observed except on the region between the 
last thoracic (T13) and the first lumbar (L1) vertebrae (Fig. 
1A and B). Table 1 summarized the axial skeletal alterations 
observed in control and DEX group. In our experimental 
groups, low dose of DEX treatment (DEX1) did not cause 
any changes in skeletal formation. Contrarily, out of 18 
embryos in the DEX10 group, 6 embryos (33%) showed a 
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pair of ectopic ribs on one or both side of L1 spinal 
column indicating an L1 to T13 transformation. In addition, 
1 embryo (6%) showed less developed T13 ribs. The ectopic 
L1 ribs were shorter than T13 ribs and varied from a stump-
like growth to a pair of bony appendages with cartilaginous 
ends (Fig. 1C and D). The upper thoracic ribs of these 
samples were similar to that of control group embryos. 
Deformed T13 ribs were shorter in length compared to 
those of control group embryos (Fig. 1E). In this embryo, 
upper ribs such as T10, 11 and 12 also seemed to be less 
developed, as their costal cartilages were shorter and less 
curved around the chest cavity than those of control group 
embryos. There was no sex preference on these phenotypes. 
Effect of prenatal DEX treatment on the protrusion of 
xiphoid process 
The xiphoid process, indicated in Fig. 2A, is a small 
cartilaginous process (extension) of the lower part of the 
sternum. Examination of the sternum have revealed that 
the xiphoid process in embryos from experimental groups 
was bent more outward or inward compared to those of 
control group (Fig. 2B-D and Fig. 3). The y-axis presented 
in Fig. 3 was an angle between the sternum and the 
protruding end of the xiphoid process in each embryo. The 
individuals belonging to the upper outside from the strong 
dotted line (Mean + SD) in the graph were the embryos 
possessing xiphoid process that points outward from of the 
rib cage which bent the sternum into a convex shape (Fig. 
2C). In contrast, the ones belonging to the lower outside 
from the weak dotted line (Mean - SD) showed inward 
pointing xiphoid process that bent the sternum into a 
concave shape (Fig. 2D). Female embryos in control saline 
group were distributed almost equally on the outside or 
within the criteria 'Mean ± SD'. Whereas, large proportion 
of female embryos in DEX1 group (8 out of 9 females) 
Table 1. Axial skeletal abnormalities found in embryos exposed 
to prenatal DEX or saline 
Treatments Axial skeletal malformation 
Saline (n=18) L1 to T13 (n=2) 11% 
DEX1 (n=18) None  0% 
DEX10 (n=18) L1 to T13 (n=6) 33% 
Abnormal T13 (n=1)  6% 
A 
C 
B
D E
Fig. 1. Axial skeletal abnormalities found in mouse embryos after prenatal exposure to DEX. (A) Overview of skeletons with normal
number of thoracic, lumbar, sacral and caudal vertebra. (B) Dorsal view showing normal thoracic vertebrae and rib attachments. (C-D)
Anterior transformation of the first lumbar (L1) vertebra in the 13th thoracic (T13) vertebra (C: one side, D; both sides). In (E), the thirteenth
rib on T13 was degenerated. 
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role of GC in regulating bone formation, GCs have been 
implicated in the induction of osteoblast differentiation and 
maintenance of bone homeostasis on a physiological level 
(Eijken et al., 2006; Henneicke et al., 2014). However, 
depending on GC dose and duration of experimental con- 
dition, as well as in the clinical use of GC for therapy, excess 
GC has been frequently caused negative effects, such as 
bone loss or osteoporosis (Weinstein 2011; Henneicke et al., 
2014). Similar to the undesirable results of excess GC on 
bones during the postnatal and adult stages, prenatal GC 
may also affect skeletal formation during fetal stages and 
can be programmed. 
Maternal restraint stress or DEX exposure in animal 
models resulted in vertebral and sternal abnormalities, and 
the retardation of somite and limb formation (Śliwa et al., 
2006; Lee et al., 2008; Choe et al., 2011). Several human 
studies have demonstrated that prenatal GC treatment led 
to a transient suppression of the levels of carboxy-terminal 
propeptide of type I collage (PICP) and carboxy-teminal 
telopeptide of type I collagen (ICTP), a measure to assess 
the rate of bone formation and resorptive, respectively, but 
with no long-term impact (Korakaki et al., 2007; Korakaki 
et al., 2011). However, interestingly enough, Gale et al. 
have shown that genetic and/or intrauterine environmental 
factors influenced the fetal growth trajectory and suggested 
an evidence that low birth weight was associated with lower 
adult bone and muscle mass, and the risk of osteoporosis in 
later life (Gale et al., 2001). Therefore, the effects of prenatal 
GC or other type of stress on bone formation during fetal 
development and potential impacts over the whole life need 
to be investigated by specific details. 
The vertebrate axial skeleton is composed of cervical, 
thoracic, lumbar, sacral and caudal regions, with vertebrae 
in each region. The whole process of the vertebrae formula, 
from the somite differentiation to the segmentation and the 
formation of the axial skeleton, is controlled by a variety of 
molecules, including transcription factors, like the members 
of the Hox and Cdx gene family, and signaling molecules, 
such as Gdf11, FGF, retinoid acid (RA) or WNT signaling 
(Mallo et al., 2009). Although there has been no report 
showing direct connections between the genesis of segmental 
identity and the GC signaling, GC may affect in the develop- 
mental process of axial skeleton formation by affecting other 
signaling pathways or regulating expression of transcription 
factors. An evidence showing functional interaction between 
GC and RA signaling and the resulting effect on Hox gene 
expression has been demonstrated (Subramaniam et al., 
2003). Furthermore, several Hox genes, such as Hoxa5, a9, 
and c10, has been proposed as GC-regulated genes, in 
mouse skin (Donet et al., 2008). We have been previously 
demonstrated that prenatal DEX exposure induces dysregu- 
lation of Hox gene expression in mouse embryos (Kim et 
al., 2011). The similarities of the prenatal DEX-induced 
phenotypes on skeleton observed in this study, e.g. an 
ectopic ribs on the L1 vertebrae, with those found in mutants 
for the Hox paralogous groups 8-10 (Favier and Dolle 1997; 
van Den Akker et al., 2001; Wellik and Capecchi 2003) 
suggest possible molecular mechanisms that underlie the 
detrimental effects of prenatal DEX on skeletal development. 
Although there were 2 embryos showing supernumerary 
ribs on the L1 in control group, natural occurrence of the 
homeotic transformation have been also found at low 
frequencies within a wild-type population in other studies 
(del Mar Lorente et al., 2000; van Den Akker et al., 2001; 
Lorente et al., 2006). Therefore, we do not think that saline 
injection only caused significant changes in axial skeleton. 
Table 2. Number of embryos belonging to the designated area depending on the angle between the sternum and the protruding end of the 
xiphoid process 
 Female Male Saline Dex1 Dex10 Saline Dex1 Dex10 
Within Mean ± SD of saline group 5 (56) 1 (11) 6 (50) 8 (89) 5 (56) 8 (67) 
Outside of Mean ± SD of saline group 4 (44) 8 (89) 6 (50) 1 (11) 4 (44) 3 (33) 
The number in parentheses represents a percentage of embryo of a given population. 
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Xiphoid process is a small cartilaginous extension of the 
lower part of the sternum which is usually ossified in the 
adult human. The abnormal forward or inward curvature of 
xiphoid process are not detrimental to the overall health 
status, but may contribute to the anatomically significant 
chest deformities, such as pectus excavatum (PE) and pectus 
carinatum (PC). Patients with PE and PC deformities may 
feel uncomfortable strains and are unsatisfied with a 
cosmetic deformity; however, depending on severity, those 
can impair cardiac and pulmonary function that will be 
considered for surgical correction (Fokin et al., 2009; 
Robicsek et al., 2009). Although these type of abnormalities 
are congenital, neither the systematic analysis of the genetic 
and molecular mechanisms nor the effects of the early 
uterine environment have been identified. Based on our 
observation, the angle divergence between the sternum and 
the protruding end of the xiphoid process was bigger in 
female embryos than in male embryos. Sex differences in 
the effect of prenatal glucocorticoid exposure or stress have 
now been issued in this field (Bale 2011; Glover and Hill 
2012). By the time, the focus of investigation was mostly 
on sex specific differences in placental function (Cuffe et al., 
2011; O'Connell et al., 2011) or sex-biased hypothalamic-
pituitary-adrenal (HPA) axis activities (Mueller and Bale 
2008; Garcia-Caceres et al., 2010), but there was no report 
about sex differences in the effect of prenatal stress on the 
skeletal development in fetuses. Our results showing a 
sex-biased variation in the protrusion of xiphoid process by 
prenatal DEX exposure could have important implications 
for the causative effect of uterine environment to the skeletal 
deformities. 
Unexpectedly, it was found that administration of high 
dose of DEX showed less angle change than the low dose 
of DEX did, as shown in Table 2 and Fig. 3. In a similar 
way, embryonic weight and size were less affected by 
prenatal administration of DEX10 than DEX1 (Yun et al., 
2014). Although it is not clear how embryos strive for 
survival, there should be some complementary mechanisms 
to overcome unfavorable intrauterine conditions, which could 
be one reason for less effect with high dose of DEX. We 
have already demonstrated that a subgroup of placentas 
from DEX10-injected mother was enlarged with structural 
abnormalities (Lee et al., 2012). Placentomegaly has been 
also observed in maternally stressed animal models and 
human, and therefore, it was regarded as a complementary 
survival strategy to adapt to an adverse condition (Faichney 
and White 1987; Lumey 1998; McCrabb et al., 1992; 
Tegethoff et al., 2010). 
In summary, our results demonstrate that prenatal expo- 
sure to DEX in mice induces fetal skeletal malformations. 
Although all of the observable skeletal phenotypes in 
prenatal stress models of previously published studies are 
not identical, it should be determined by the timing and the 
amount of fetal exposure to stress, and by the genetic 
susceptibility. Therefore, all outcomes from individual studies 
might provide valuable information and understanding how 
prenatal maternal stress can affect a developing fetus. Further 
investigations on the molecular basis behind the phenotypes 
would be helpful to evaluate the effects on fetal skeletal 
system. 
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